Abstract

Three months ago, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) broke out in Wuhan, China, and spread rapidly around the world. Severe novel coronavirus pneumonia (NCP) patients have abnormal blood coagulation function, but their venous thromboembolism (VTE) prevalence is still rarely mentioned.

Keywords

MedicinePneumoniaCoronavirusCoronavirus disease 2019 (COVID-19)Venous thromboembolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoagulationIntensive care medicineInternal medicineThrombosisVirologyDiseaseOutbreakInfectious disease (medical specialty)

MeSH Terms

AdultAgedBetacoronavirusBiomarkersBlood CoagulationBlood Coagulation TestsCOVID-19ChinaCoronavirus InfectionsFemaleFibrin Fibrinogen Degradation ProductsHumansIncidenceMaleMiddle AgedPandemicsPneumoniaViralPredictive Value of TestsPrevalencePrognosisReproducibility of ResultsRetrospective StudiesRisk AssessmentRisk FactorsSARS-CoV-2Severity of Illness IndexVenous Thromboembolism

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
18
Issue
6
Pages
1421-1424
Citations
1877
Access
Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1877
OpenAlex
111
Influential
1390
CrossRef

Cite This

Songping Cui, Shuo Chen, Xiunan Li et al. (2020). Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis , 18 (6) , 1421-1424. https://doi.org/10.1111/jth.14830

Identifiers

DOI
10.1111/jth.14830
PMID
32271988
PMCID
PMC7262324

Data Quality

Data completeness: 86%